Ask AI

On-Demand Webcast

Share

Program Content

Activities

  • 1L TROP2 ADC Evidence
    mTNBC Practice Readiness: Applying Current Standards and Interpreting Emerging First-line TROP2 ADC Evidence for Immunotherapy-Ineligible Patients
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 13, 2026

    Expires: April 12, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.